Overview

The vision of the European Partnership for Personalised Medicine (EP PerMed) is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society. A major activity towards this goal will be the active support of PM-related research and innovation projects. In this context, EP PerMed will fund Joint Transnational Calls for Research Proposals, act as global PM-platform for scientific and strategic dialogue and alignment, facilitate and accelerate all steps of implementation through the full value continuum, so that PM achievements can be successfully implemented and foster demonstration projects and promote successes and lessons learned to demonstrate evidence of PM implementation. The proposal for the European Partnership for Personalised Medicine was positively evaluated by the European Commission in August 2023. Grant Agreement negotiations are ongoing. The project start is expected for the end of 2023. Imprint: https://www.dlr.de/en/service/imprint Data privacy: https://www.dlr.de/en/service/privacypolicy This channel is managed by the project coordinator DLR Projektträger.